Designing green derivatives of β-blocker Metoprolol: A tiered approach for green and sustainable pharmacy and chemistry
Research output: Journal contributions › Journal articles › Research › peer-review
Standard
In: Chemosphere, Vol. 111, 01.09.2014, p. 493-499.
Research output: Journal contributions › Journal articles › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Designing green derivatives of β-blocker Metoprolol
T2 - A tiered approach for green and sustainable pharmacy and chemistry
AU - Rastogi, Tushar
AU - Leder, Christoph
AU - Kümmerer, Klaus
N1 - Copyright © 2014 Elsevier Ltd. All rights reserved.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - The presences of micro-pollutants (active pharmaceutical ingredients, APIs) are increasingly seen as a challenge of the sustainable management of water resources worldwide due to ineffective effluent treatment and other measures for their input prevention. Therefore, novel approaches are needed like designing greener pharmaceuticals, i.e. better biodegradability in the environment. This study addresses a tiered approach of implementing green and sustainable chemistry principles for theoretically designing better biodegradable and pharmacologically improved pharmaceuticals. Photodegradation process coupled with LC-MS(n) analysis and in silico tools such as quantitative structure-activity relationships (QSAR) analysis and molecular docking proved to be a very significant approach for the preliminary stages of designing chemical structures that would fit into the "benign by design" concept in the direction of green and sustainable pharmacy. Metoprolol (MTL) was used as an example, which itself is not readily biodegradable under conditions found in sewage treatment and the aquatic environment. The study provides the theoretical design of new derivatives of MTL which might have the same or improved pharmacological activity and are more degradable in the environment than MTL. However, the in silico toxicity prediction by QSAR of those photo-TPs indicated few of them might be possibly mutagenic and require further testing. This novel approach of theoretically designing 'green' pharmaceuticals can be considered as a step forward towards the green and sustainable pharmacy field. However, more knowledge and further experience have to be collected on the full scope, opportunities and limitations of this approach.
AB - The presences of micro-pollutants (active pharmaceutical ingredients, APIs) are increasingly seen as a challenge of the sustainable management of water resources worldwide due to ineffective effluent treatment and other measures for their input prevention. Therefore, novel approaches are needed like designing greener pharmaceuticals, i.e. better biodegradability in the environment. This study addresses a tiered approach of implementing green and sustainable chemistry principles for theoretically designing better biodegradable and pharmacologically improved pharmaceuticals. Photodegradation process coupled with LC-MS(n) analysis and in silico tools such as quantitative structure-activity relationships (QSAR) analysis and molecular docking proved to be a very significant approach for the preliminary stages of designing chemical structures that would fit into the "benign by design" concept in the direction of green and sustainable pharmacy. Metoprolol (MTL) was used as an example, which itself is not readily biodegradable under conditions found in sewage treatment and the aquatic environment. The study provides the theoretical design of new derivatives of MTL which might have the same or improved pharmacological activity and are more degradable in the environment than MTL. However, the in silico toxicity prediction by QSAR of those photo-TPs indicated few of them might be possibly mutagenic and require further testing. This novel approach of theoretically designing 'green' pharmaceuticals can be considered as a step forward towards the green and sustainable pharmacy field. However, more knowledge and further experience have to be collected on the full scope, opportunities and limitations of this approach.
KW - Chemistry
KW - Sustainable chemistry
KW - Sustainable pharmacy
KW - Metoprolol
KW - beta-blocker
KW - Sustainability Science
KW - (Quantitative) Structure-activity relationships (QSAR)
KW - Benign by design
KW - Beta adrenergic receptor
KW - Metoprolol
KW - Molecular docking
KW - Photolysis
UR - http://www.scopus.com/inward/record.url?scp=84903633656&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/d5356701-df38-30cd-8692-8f4b24ebb988/
U2 - 10.1016/j.chemosphere.2014.03.119
DO - 10.1016/j.chemosphere.2014.03.119
M3 - Journal articles
C2 - 24997957
VL - 111
SP - 493
EP - 499
JO - Chemosphere
JF - Chemosphere
SN - 0045-6535
ER -